Cti tracker

The Contraceptive Technology Innovation Tracker—CTI Tracker—houses information on potential contraceptive leads in early development, products in pre-clinical and clinical development, and products with single-country regulatory approval. The Tracker reports on both active development platforms and inactive R&D.

Contraceptive Pipeline Baseline Report ⬇ Export Database

For more information about contraceptive R&D, visit our partner databases

Show Filters
Inactive
Last updated: March 23, 2026
Emergency Oral Meloxicam
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Oral
  • Intended Duration: Emergency
  • Development Stage: Phase I
  • Developer(s)/Researcher(s): CONRAD, ICMER
Inactive
Last updated: January 13, 2026
Emergency DMPA Injectable
  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Injectable
  • Intended Duration: Emergency
  • Development Stage: Phase I
  • Developer(s)/Researcher(s): University of Southern California
Inactive
Last updated: January 13, 2026
Umbrella Reversible Sterilization Device
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Fallopian Tube
  • Intended Duration: Permanent
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): Third Xiangya Hospital of Central South University, Shanghai East Hospital of Tongji University
Inactive
Last updated: January 13, 2026
Weekly Combined Oral Contraceptive
  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Oral
  • Intended Duration: Short-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Lyndra Therapeutics, Massachusetts Institute of Technology
Inactive
Last updated: January 7, 2026
Copper + LDPE Nanocomposite IUD

Cu/LDPE/MVQ IUD

  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Intrauterine
  • Intended Duration: Long-Acting
  • Development Stage: Phase II
  • Developer(s)/Researcher(s): Tongji Medical College at Huazhong University of Science and Technology Dayu Medical Devices
Inactive
Last updated: January 7, 2026
Progestin-Only Cream

Mini-Pill Cream, VML-030X

  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Transdermal
  • Intended Duration: Short-Acting
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): Viramal Limited
Inactive
Last updated: January 7, 2026
Polymer Coated Copper IUD

Coated Copper T

  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Intrauterine
  • Intended Duration: Long-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): HLL Lifecare Limited / INIFTA
Inactive
Last updated: January 7, 2026
MENTR Implant

MENT Acetate Implant, 7alpha-Methyl-19-Nortestosterone, MENTR

  • User: Male
  • Hormonal: Hormonal
  • Delivery Type: Subdermal
  • Intended Duration: Long-Acting
  • Development Stage: Phase II
  • Developer(s)/Researcher(s): Population Council
Inactive
Last updated: January 7, 2026
Meloxicam Vaginal Ring
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Vaginal Ring
  • Intended Duration: Short-Acting
  • Development Stage: Phase I
  • Developer(s)/Researcher(s): Laboratorios Andromaco, ICMER
Inactive
Last updated: January 7, 2026
Lupeol

Lup-20(29)-en-3-ol, (3beta)-, Fagarasterol, Clerodol, Monogynol B

  • User: Female/Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Not Yet Determined
  • Intended Duration: Not Yet Determined
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): UC Berkeley, YourChoice Therapeutics